EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease

Chuanyu Yu, Xueyan Liu, Bingxiang Ma, Jiexin Xu, Yiquan Chen, Chaoxian Dai, Huaping Peng, Daijun Zha

Journal of Enzyme Inhibition and Medicinal Chemistry · 31.12.2024 · 39 (1)

DOI: 10.1080/14756366.2024.2313682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, online erschienen am 16.02.2024. Verfasst von Chuanyu Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian Province, China. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, Talented Scholars of Fujian Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Butyrylcholinesterase (BuChE) and neuroinflammation have recently emerged as promising therapeutic directions for Alzheimer's disease (AD). Herein, we synthesised 19 novel pyranone-carbamate derivatives and evaluated their activities against cholinesterases and neuroinflammation. The optimal compound 7p exhibited balanced BuChE inhibitory activity (eqBuChE IC50 = 4.68 nM; huBuChE IC50 = 9.12 nM) and anti-neuroinflammatory activity (NO inhibition = 28.82% at 10 μM, comparable to hydrocortisone). Enzyme kinetic and docking studies confirmed compound 7p was a mix-type BuChE inhibitor. Additionally, compound 7p displayed favourable drug-likeness properties in silico prediction, and exhibited high BBB permeability in the PAMPA-BBB assay. Compound 7p had good safety in vivo as verified by an acute toxicity assay (LD50 > 1000 mg/kg). Most importantly, compound 7p effectively mitigated cognitive and memory impairments in the scopolamine-induced mouse model, showing comparable effects to Rivastigmine. Therefore, we envisioned that compound 7p could serve as a promising lead compound for treating AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMiceAnimalsButyrylcholinesteraseCarbamatesNeuroinflammatory DiseasesAmyloid beta-PeptidesCholinesterase InhibitorsAcetylcholinesteraseStructure-Activity RelationshipMolecular Docking SimulationMolecular Structure

Stichwörter der Autor:innen

Alzheimer’s diseaseanti-neuroinflammationbutyrylcholinesterase inhibitorscognitive improvementpyranone-carbamate derivatives

Substanzen

ButyrylcholinesteraseCarbamatesAmyloid beta-PeptidesCholinesterase InhibitorsAcetylcholinesterase

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian Province, China.
  • Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fujian Medical University, Fuzhou, Fujian Province, China.
  • Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian Province, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province
  • Talented Scholars of Fujian Medical University

Zitieren

APA

Yu, C., Liu, X., Ma, B., Xu, J., Chen, Y., Dai, C., Peng, H., & Zha, D. (2024). Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry, 39(1). https://doi.org/10.1080/14756366.2024.2313682

Vancouver

Yu C, Liu X, Ma B, Xu J, Chen Y, Dai C, et al. Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 2024;39(1). doi:10.1080/14756366.2024.2313682

BibTeX
@article{Yu2024,
  author = {Yu, Chuanyu and Liu, Xueyan and Ma, Bingxiang and Xu, Jiexin and Chen, Yiquan and Dai, Chaoxian and Peng, Huaping and Zha, Daijun},
  title = {Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2024},
  volume = {39},
  number = {1},
  doi = {10.1080/14756366.2024.2313682}
}
Kostenlos starten →